title: Long-term survivors in stage IV non-small cell lung cancer.
abstract: OBJECTIVE
  To determine the prognostic factors for long-term survivors (LTS) with stage IV non-small cell lung cancer (NSCLC) who had undergone various treatments.
  
  
  METHODS
  From 1990 to 1999, 222 NSCLC patients with stage IV disease, who had been treated in our department, were reviewed. As the initial treatment, 135 patients (48%) were treated with chemotherapy alone, 52 patients with a combination of chemotherapy and radiotherapy, 19 patients underwent an operation with or without any other therapeutic modalities and 16 were received radiotherapy alone.
  
  
  RESULTS
  Seventeen (7.7%) patients survived for more than 2 years, and all but one had adenocarcinoma. Among these LTS, eight patients received surgery as the initial therapy, and 16 (94.1%) received some type of local-control therapy, including surgery or radiotherapy, during the course of their disease. Regarding the clinical characteristics between LTS and others (non-LTS), an early N status, a single metastatic site, a good performance status, and surgery for initial therapy were all found to be significantly important factors for LTS. A multivariate analysis using a logistic regression model also showed an early N status and surgical treatment to be significantly associated with LTS.
  
  
  CONCLUSIONS
  Selected patients with an early N status may be appropriate candidates for aggressive multimodality treatment including surgery, in order to provide a long-term survival for stage IV NSCLC.
authors.affiliation: Department of Thoracic Oncology, National Kyushu Cancer Center, 3-1-1, Notame, Minami-ku, Fukuoka 811-1395, Japan. tokamoto@nk-cc.go.jp
authors.forename: Tatsuro
authors.initials: T
authors.lastname: Okamoto
authors.forename: Riichiroh
authors.initials: R
authors.lastname: Maruyama
authors.forename: Fumihiro
authors.initials: F
authors.lastname: Shoji
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Asoh
authors.forename: Jiro
authors.initials: J
authors.lastname: Ikeda
authors.forename: Tetsuya
authors.initials: T
authors.lastname: Miyamoto
authors.forename: Tomomi
authors.initials: T
authors.lastname: Nakamura
authors.forename: Tetsuro
authors.initials: T
authors.lastname: Miyake
authors.forename: Yukito
authors.initials: Y
authors.lastname: Ichinose
mesh_terms: D000368:Aged; D002289:Carcinoma, Non-Small-Cell Lung / Q000473:pathology* / Q000628:therapy; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006304:Health Status; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D011379:Prognosis; D018714:Radiotherapy, Adjuvant; D016019:Survival Analysis